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Abstract
Background: In sub-Saharan Africa, non-typhoidal Salmonella (NTS) can cause bloodstream infections, referred to as
invasive non-typhoidal Salmonella disease (iNTS disease); it can occur in outbreaks and is often preceded by malaria.
Data from Central Africa is limited.
Methods: Clinical, microbiological and molecular findings of NTS recovered in a blood culture surveillance project
(2009–2014) were analyzed.
Results: In March-July 2012 there was an epidemic increase in malaria infections in the Oriental Province of the
Democratic Republic of the Congo (DRC). In one referral hospital, overall hospital admissions in June 2012 were
2.6 times higher as compared to the same period in the years before and after (336 versus an average of 128
respectively); numbers of malaria cases and blood transfusions were nearly three- and five-fold higher respectively
(317 versus 112 and 250 versus 55). Case fatality rates (in-hospital deaths versus all admissions) peaked at 14.6 %.
Salmonella Typhimurium and Salmonella Enteritidis together accounted for 88.9 % of pathogens isolated from
blood cultures collected during an outreach visit to the affected districts in June 2012. Children infected with
Salmonella Enteritidis (33 patient files available) tended to be co-infected with Plasmodium falciparum more often
than children infected with Salmonella Typhimurium (40 patients files available) (81.8 % versus 62.5 %). Through the
microbiological surveillance project (May 2009–May 2014) 113 unique NTS isolates were collected (28.5 % (113/396)
of pathogens); most (95.3 %) were recovered from children < 15 years. Salmonella Typhimurium (n = 54) and Salmonella
Enteritidis (n = 56) accounted for 47.8 % and of 49.6 % NTS isolates respectively. Multilocus variable-number
tandem-repeat analysis (MLVA) revealed more heterogeneity for Salmonella Typhimurium than for Salmonella
Enteritidis. Most (82/96, 85.4 %) NTS isolates that were available for antibiotic susceptibility testing were
multidrug resistant. All isolates were susceptible to ceftriaxone and azithromycin.
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Conclusion: During the peak of an epidemic increase in malaria in the DRC in 2012, a high proportion of
multidrug resistant Salmonella Typhimurium and Salmonella Enteritidis were isolated from blood cultures.
Overall, the two serovars showed subtle differences in clinical presentation and genetic diversity.
Keywords: Bloodstream infections, Salmonella, Democratic Republic of the Congo, Antibiotic, Molecular
typing, Symptoms, Children, Malaria
Background
In industrialized countries, non-typhoidal Salmonella
(NTS, i.e., Salmonella serovars other than Salmonella
enterica serovar Typhi and Salmonella enterica serovar
Paratyphi) are associated with self-limiting diarrhea. In
sub-Saharan Africa however, they often cause blood-
stream infections, which is referred to as invasive non-
typhoidal Salmonella disease (iNTS disease). They are
among the pathogens most frequently isolated from
blood cultures [1–4]. In fact, iNTS disease poses an
important public health problem with an estimated
population-based annual incidence of 175–388 cases/
100,000 in children aged 3–5 years of age [2]. Due to the
lack of microbiological facilities in many African coun-
tries, the true burden of iNTS disease is not well known
and the condition remains undiagnosed and hence invis-
ible and neglected.
iNTS disease occurs mainly in children and immune-
compromised individuals and a number of conditions
make individuals more susceptible including malnutri-
tion and Plasmodium falciparum malaria [5–9]. The two
NTS serovars most prevalent in sub-Saharan Africa are
Salmonella enterica serovar Typhimurium (hereafter re-
ferred to as Salmonella Typhimurium) and Salmonella
enterica serovar Enteritidis (hereafter referred to as
Salmonella Enteritidis).
Studies about NTS infections in children have been
reported mainly from East, West and South Africa
[1, 10–14]. Recently, epidemic increases of NTS in-
fections were reported from the Democratic Republic of
the Congo (DRC) in Central Africa; in Kisantu in 2011
(South West, Bas Congo Province) and in Bwamanda in
2012 (North West, Equatorial Province) [15, 16] (Fig. 1).
In April 2012, local health authorities in the district of
Haut-Uélé (North East, Oriental Province) (Fig. 2) were
alerted by significant increases in numbers of hospitals
admissions, blood transfusions and case fatality rates
among children. This observation was also made in the
neighboring district of Bas-Uélé and was related to an
increase of malaria infections as reported by different
organizations at that time [17].
However, most children did not respond favorably to
antimalarials but improved when antibiotics were ad-
ministered. This raised suspicion of a concomitant
increase in NTS infections as was previously witnessed
in Bwamanda and Kisantu and resulted in the Ministry
of Health recommending empirical treatment of intra-
venous quinine combined with antibiotics (ceftriaxone
or ciprofloxacin) to all affected children. Blood culture
sampling in the affected districts allowed assessment of
a possible concomitant burden of invasive Salmonella
infections. Due to logistic and administrative difficulties,
sampling was only initiated from June 2012 onwards.
Site visits also included reviewing of clinical charts of
pediatric patients with invasive salmonellosis.
The present report aims to describe the clinical,
microbiological, and molecular characteristics of the
invasive Salmonella infections observed during this
period of increased admissions and malaria infections
in the Bas-Uélé and Haut-Uélé districts as well as of
invasive Salmonella infections recorded in the entire




The Oriental Province in the DRC covers an area of
503,239 km2 with 8,633,573 inhabitants and com-
prises four administrative districts: Tshopo (including
Kisangani, province capital), Haut-Uélé, Bas-Uélé and
Ituri. Each district is divided into health zones (HZs)
with a General Referral Hospital. The four health zones
mainly affected by an epidemic increase in malaria in
2012 were located in the districts Haut-Uélé (HZs of
Wamba and Isiro) and Bas-Uélé (HZs of Pawa and Poko)
(Fig. 2). Demographic data of these HZs are displayed in
Table 1. The majority of the population is living from agri-
culture, livestock, informal trade and small-scale mining
[18]. There is a tropical rainforest climate with peaks of
rainfall in April and October and a dryer season between
November and February. Malaria is the leading cause of
morbidity and mortality among children and P. falcip-
arum is holoendemic with a perennial transmission [19].
During the year 2012, the Eastern DRC experienced
increases in violence due to various armed groups
leading to 466,000 displaced persons in the Oriental
Province [20]. Apart from the reported increase in mal-
aria infections, the province also faced outbreaks of
cholera, measles and meningitis [21]. The control of
these outbreaks was tempered by ongoing insecurity and
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poor transport infrastructure including the absence of
paved roads.
Blood culture surveillance network, CUKIS, Kisangani
The University Hospital of Kisangani (CUKIS), located
in the capital of the Oriental Province, has basic labora-
tory infrastructure performing blood cultures and is par-
ticipating in the microbiological surveillance network
coordinated by the National Institute of Biomedical
Research (INRB) in Kinshasa in collaboration with the
Institute of Tropical Medicine (ITM) in Antwerp,
Belgium. This network monitors the pathogens involved
in bloodstream infections and their antibiotic resistance
patterns at various sentinel sites in the DRC. CUKIS
receives samples from hospitals and health centers in
Kisangani and from more remote sites during outbreak
investigations. CUKIS is located at 445 km from the HZ
Wamba, 519 km from the HZ Pawa, 571 km from the
HZ Isiro and 691 km from the HZ Poko.
Criteria for blood cultures sampling in patients >28 days
of age were: (1) a body temperature of ≥38 °C or ≤35.5 °C;
(2) suspicion of severe localized infections; or (3) suspicion
of sepsis, typhoid fever, and severe malaria. Additional cri-
teria for collection of blood specimens from women in the
neonatal period were premature rupture of membranes,
intrapartum fever, low Apgar score, or specific symptoms
such as tachypnea, cyanosis, and lethargy. For children
(≤14 years old), 1–4 mL of blood was sampled into a
pediatric blood culture vial (BacT/ALERT PF, bioMérieux,
Marcy L’Etoile, France); for adults, 2 × 10 mL of blood was
inoculated into aerobic blood culture vials (BacT/ALERT
FA, bioMérieux) and incubated at 35 °C for 7 days. Blood
cultures were processed according to standard methods as
described elsewhere [22, 23]. All isolates were stored in
tubes of Trypticase Soya Agar (Oxoid, Basingstoke,
UK) and shipped to ITM for confirmation and further
identification.
Serotyping and antibiotic susceptibility
At ITM, isolates biochemically confirmed as Salmonella
spp. were serotyped using commercial antisera (Sifin,
Berlin, Germany). A selection of the isolates were sent to
the National Reference Centre in Belgium for confirmation
of serotyping by slide agglutination following the
Kauffmann-White scheme [24]. Selection of these iso-
lates was based on differences in year and location of
collection.
Susceptibility testing of the isolates and interpret-
ation of results were done according to the National
Committee for Clinical Laboratory Standards (CLSI)
guidelines as described elsewhere [23]. Antibiotic suscepti-
bility tests were performed with the E-test macromethod
(bioMérieux) (azithromycin, ciprofloxacin) or disk diffu-
sion (Neo-Sensitabs, Rosco, Taastrup, Denmark) (all other
Fig. 1 Map of DRC with the three places recently affected by a microbiologically documented (epidemic) increase in Salmonella infections (i)
Kisantu [15]; (ii) Bwamanda [16]; (iii) districts of Bas-Uélé and Haut-Uélé (present report). © Institute of Tropical Medicine, Antwerp
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antibiotics). Multidrug resistance (MDR) was defined as
co-resistance to all three first-line antibiotics ampicillin,
chloramphenicol and trimethoprim-sulfamethoxazole [25].
The methods described apply equally to ongoing sur-
veillance efforts and to the additional site visits done in
2012/2013.
Determinations of mutations responsible for decreased
ciprofloxacin susceptibility
Molecular mechanisms of ciprofloxacin resistance were
assessed by amplification and sequencing of the quin-
olone resistance determining regions (QRDRs) of the
gyrA, gyrB, and parC genes as previously described [26].
The fragments were sequenced on an ABI 3130
sequencer. The presence of the plasmid-mediated quin-
olone resistance qnr genes (qnrA, qnrB and qnrS) was
determined using PCR [27].
Multiple-locus variable-number of tandem repeats
analysis (MLVA) and assessment of clonality of Salmonella
Enteritidis and Salmonella Typhimurium isolates
To assess the clonal relatedness among Salmonella
Enteritidis and Salmonella Typhimurium isolates, MLVA
analysis was performed on all isolates as previously de-
scribed [28, 29]. For Salmonella Enteritidis, profiles were
attributed based on the number of tandem repeats on
five loci in the following order: SENTR7−, SENTR5−,
SENTR6−, SENTR4− and SE3-. For Salmonella
Table 1 Demographic characteristics of the affected health zones (Pawa, Wamba, Poko and Isiro), Oriental Province, DRC
Health zones HGR capacity
(numbers of beds)




Pawa 110 2415 157,657 4.7 12.2
Wamba 80 8203 130,473 6.2 10.4
Poko 100 10,876 168,567 5.7 13.3
Isiro 140 1646 208,658 4.5 7.6
HGR General Referral Hospital
Fig. 2 The four health zones affected by the iNTS disease outbreak in 2012: Wamba and Isiro (Haut-Uélé) and Pawa and Poko (Bas-Uélé).
© Institute of Tropical Medicine, Antwerp
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Typhimurium, profiles were attributed based on the
number of tandem repeats on five loci in the following
order: STTR9-, STTR5-, STTR6-, STTR10- and STTR3-.
Simpson’s index of diversity (D) and Shannon’s indices of
diversity (H’) and equitability (E) were calculated to evalu-
ate the discriminatory power and evenness of distribution
by using the Biodiversity Calculator [30].
Clinical data
Outreach visits to the HZs of Pawa, Isiro, Poko and
Wamba were performed by an INRB team and a CUKIS
collaborator (DF) in June/July 2012 and to the HZ of
Pawa in the period October 2012–January 2013. During
these and additional visits, clinical data from all children
with a documented Salmonella bloodstream infection
between 2009 and 2014 were retrieved from patient files.
Data recorded included age, gender, weight and geo-
graphic origin, clinical presentation, diagnosis upon
admission, number of blood transfusions, in-hospital
outcome, Hb-value (Sahli method [31]) and parasite-
based diagnosis of malaria (diagnosed either by micros-
copy or by rapid diagnostic test). Blood transfusions had
been administered according to the criteria established
by the national program of blood transfusion [32],
i.e., Hb value below 6 g/dl or signs of respiratory and
circulatory failure. Anemia was defined as an Hb-
value < 11 g/dl and severe anemia was defined as an
Hb-value < 5 g/dl. Nutritional status was assessed by
the weight-for-age method which for children under
5 years compares the actual weight of the child to
the referral charts indicating the ideal weight-for-age
and defines low and very low weight-for-age (≤ −2 SD
and ≤−3 SD from the reference respectively) [33]. No data
on child height, HIV status or malaria density was avail-
able. The patient files of children who did not have a
confirmed Salmonella bloodstream infection were not
reviewed.
Data on hospital admissions and case-fatality rates
were collected from the hospital registers and concerned
all patients admitted to the pediatric ward. For the
General Referral Hospital of Poko, blood transfusion
files for the year 2011 could not be retrieved.
Data on rainfall and climate
Data of rainfall in the Oriental Province (2011–2013)
were retrieved from the Global Information and Early
Warning System from the Food and Agriculture
organization of the United Nations [34].
Data registration, statistical analysis
Demographic, clinical and microbiological data were en-
tered anonymously into an Excel database (Microsoft,
Redmond, WA, USA). Only the first isolate for each pa-
tient was considered, isolates recovered from a second
blood culture drawn within two weeks after the initial
one were considered as duplicates, whereas isolates re-
covered from a repeat blood culture more than two
weeks after the initial one were considered as recur-
rences (either relapse or repeat infections). Statistical
analysis was done with Stata 12 (Stata Corp., College
Station, TX, USA). P values and (adjusted) odds ratio’s
(OR) were calculated by univariate and multivariate lo-
gistic regression analysis. When one group contained
zero observations for a particular variable, the p value
was calculated with a two tailed Fisher’s exact test
instead.
It was decided only to keep the categorical variables
anemia and severe anemia rather than the continuous
variable of hemoglobin level (g/dL), because of the limi-
tations of the measurement (Sahli method) and because
it seemed more relevant clinically. When multiple
variables differed statistically between groups at a level
of P <0.100 and were also clinically relevant, they were
further assessed in a multivariable logistic regression
analysis. Diagnoses upon admission were not included in
the multivariate analysis. To assess the influence of mal-
aria positivity, initial analysis was done stratified for mal-
aria positivity. Stepwise backward regression was used to
eliminate variables that this did not retain their statis-
tical significance. Likelihood ratio testing guided the
selection of the final model. A p value of < 0.05 was con-
sidered significant.
Ethics statement
The study was conducted according to the principles
expressed in the Declaration of Helsinki. Ethical ap-
proval for the Microbiological Surveillance Study was
granted by the Institutional Review Board of the ITM,
the Ethics Committee of Antwerp University, and the
Ministry of Health of the DRC. In view of the absence of
an Ethical committee in Kisangani at the time of the
study, written authorization to review the patient files
was obtained from the Medical Inspector of the Oriental
Province (Reference number: N0 701/DPS/PERS/872/
2012) who represents the highest health authority as
well as from the Chief Medical Officer of the Haut-Uélé
district (Reference number: 771/23/ISP/HU.O/2012).
The retrieved clinical data were only accessible to the
CUKIS collaborator (DF), who is a medical doctor, and
were subsequently entered anonymously in an Excel
database with restricted access.
Results
Data of hospital admissions, blood transfusions and
malaria cases, 2011–2013
In Pawa and Wamba HZs, overall hospital admissions
increased from March 2012 onwards, reaching a peak in
May-June 2012 (Fig. 3a and b). In June 2012, numbers of
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overall admissions in Pawa were 2.6 times higher as
compared to the average of the corresponding month
during the years 2011 and 2013 (336 versus 128 respect-
ively). The same was observed in Wamba (195 admis-
sions in June 2012 vs. 77 and 74 in June 2011 and June
2013). The temporal evolution of numbers of malaria
cases and blood transfusions aligned with those of the
overall hospital admissions: in Pawa, 317 malaria cases
were recorded in June 2012, versus an average of 112 for
the other years (i.e., a nearly a three-fold increase); for
blood transfusions, the difference was almost five-fold
(250 versus 55). In Wamba a three-fold increase was
seen for the number of malaria cases in June 2012
compared to the average of other years (178 vs. 59), as
well as for the number of blood transfusions (73 in June
2012 vs. 24 in other years). The number of case fatalities
showed a similar evolution, with a total number of 49
fatalities in Pawa in June 2012 (i.e., an in-hospital case
fatality rate of 14.6 % (49/336)) versus an average of 6
cases during the same month in the other years. In
Wamba there were 16 fatalities in June 2012 vs. an aver-
age of 5 cases that month in other years. The HZs of
Poko and Isiro showed a different trend, with a similar
peak in June 2012, but with significant peaks in admis-
sion numbers and malaria cases already in 2011 (Fig. 3c
and d). The increases of 2012 occurred approximately
one month after the end of the dryer season, during
which less rainfall had been observed compared to other
years (Fig. 4).
NTS infections in the Bas-Uélé and Haut-Uélé districts,
2012-2013
In June 2012, at the request of the Ministry of Health,
INRB staff did an outreach visit to all four affected HZs.
Out of 87 blood cultures sampled, 18 (20.7 %) grew clin-
ically significant organisms (further referred to as patho-
gens), of which 16 (88.9 %) were NTS, with Salmonella
Enteritidis and Salmonella Typhimurium accounting for
nine and seven isolates respectively. Between October
2012 and January 2013 outreach visit to the HZ of Pawa
allowed sampling of another 244 blood cultures, with 38
(15.6 %) pathogens, including Salmonella Enteritidis
(n = 7) and Salmonella Typhimurium (n = 3) (26.3 %
of pathogens). After Salmonella species, the most fre-
quently isolated pathogens were Acinetobacter species
and Staphylococcus aureus.
Blood culture surveillance, CUKIS, Kisangani, Salmonella
Typhi and NTS isolates (2009 – 2014)
From May 2009 to May 2014, CUKIS processed 3467
blood cultures in total comprising 88.0 % samples (3052/
3467) from Kisangani district and 12.0 % (415/3467)
from the Haut-Uélé and Bas-Uélé districts, including
samples from the outreach visits. In total, 11.4 %
BA
DC
Fig. 3 Hospital admissions, malaria cases, blood transfusions and case-fatality rates (2011–2013) for a Pawa Health Zone Referral Hospital; b Wamba
Health Zone Referral Hospital; c Poko Health Zone Referral Hospital; d Isiro Health Zone Referral Hospital. HGR = General Referal Hospital
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(396/3467) blood cultures grew pathogens of which
34.1 % (135/396) were Salmonella. The annual proportion
varied between 25.0 % (2009–2010) and 42.3 % (2012).
Salmonella were the most commonly isolated bacteria in
both adults and children. Other frequent pathogens were
Staphylococcus aureus and Klebsiella pneumoniae. Among
the 135 Salmonella isolates, there were five duplicates (all
grown within 14 days after the day of first sampling). Of
the 130 first (unique) isolates, there were 17 Salmonella
Typhi and 113 NTS isolates.
NTS isolates Oriental Province, 2009–2014: serovars and
clonality
Salmonella Typhimurium and Salmonella Enteritidis were
the most frequent serovars accounting for approximately
half of NTS isolates each (47.8 and 49.6 % out of 113 iso-
lates respectively) (Table 2). In 2011 and 2012, Salmonella
Enteritidis outnumbered Salmonella Typhimurium and
vice versa during the years before and after. The other
NTS serovars recovered were Salmonella Kisangani and
Salmonella spI 1,4,12:-:1,2 (Salmonella group B).
MLVA analysis of the Salmonella Typhimurium isolates
revealed heterogeneity with 23 different profiles across 54
isolates collected between 2009 and 2014 (Simpson’s D =
0.95) (Additional file 1: Figure S1). The Salmonella
Typhimurium isolates also showed an even distribution
(Shannon’s H’ = 2.90 and E = 0.93). Forty-four of the 54
Salmonella Typhimurium isolates were collected in the
Tshopo district (where the provincial capital Kisangani is
located), with three major profiles accounting for only 18
isolates (40,9 %) (2-6-11-8-0210 (n = 7), 2-5-10-8-0210
(n = 6), 2-7-10-8-0210 (n = 5)) in this district. Eight
Salmonella Typhimurium isolates were collected in the
Bas-Uélé district. Of these 8, five belonged to the profile
2-8-12-8-0210, which was not isolated in the Tshopo district.
Multilocus variable-number tandem-repeat analysis
(MLVA) of the 56 Salmonella Enteritidis isolates
revealed less heterogeneity with 13 different profiles
(Simpson’s D = 0.71) (Additional file 2: Figure S2). Isolates
were unevenly distributed over the subtypes, with two
major profiles, i.e., 2-13-3-3-NA (n = 26) and 2-13-4-3-
NA (n = 15), accounting for 73.2 % of the tested isolates
(Shannon’s H’ = 1.64 and E = 0.64). Thirty-five out of the
Table 2 Distribution of Salmonella serovars among clinically significant organisms (CSO), Oriental Province, DRC, 2009–2014. Only
first isolates were considered
2009–2010* 2011 2012 2013 2014** Total
(% of all Salmonella isolates)(CSO = 92) (CSO = 83) (CSO = 78) (CSO = 89) (CSO = 54)
n (%) n (%) n (%) n (%) n (%)
Salmonella Typhi 6 1 2 5 3 17 (13.1)
Salmonella Typhimurium 9 6 13 14 12 54 (41.5)
Salmonella Enteritidis 6 16 18 13 3 56 (43.1)
Other Salmonella serovars*** 2 0 0 0 1 3 (2.3)
Total (% of CSO) 23 (25.0) 23 (27.7) 33 (42.3) 32 (35.9) 19 (35.2) 130 (100)
* Data from 2009 and 2010 are grouped together as 2009 was considered as a pilot year (training and implementation)
** For 2014, data were completed till May 27th
*** Including Salmonella group B (one isolate) and Salmonella Kisangani (two isolates)
Fig. 4 Rainfall in the Oriental Province, DRC (2011–2013). Peak months of the outbreak were April 2012 to June 2012
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56 Salmonella Enteritidis isolates were collected in the
health district of Tshopo; 26 (74,3 %) of these 35 isolates
had the major profile 2-13-3-3-NA. This profile was not
isolated in the health districts of Bas-Uélé and Haut-Uélé.
Of the 21 Salmonella Enteritidis isolates collected in the
Bas-Uélé and Haut-Uélé districts between 2009 and 2014,
17 isolates were collected in the year 2012 of which 10
belonged to the second major profile 2-13-4-3-NA.
Antibiotic resistance of Salmonella according to serovar
Susceptibility testing was done for all isolates collected
in the DRC between 2009 and 2014 as described else-
where [6, 23]. Here, we will describe the isolates col-
lected in the Oriental Province during the period 2011–
2014 (n = 107) as they were not discussed separately
from isolates collected in other provinces of the DRC
(Table 3; Additional file 3: Table S1).
In contrast to Salmonella Typhi, the majority of NTS
(82/96, 85.4 %) were MDR, and with slightly higher
resistance rates among Salmonella Typhimurium
compared to Salmonella Enteritidis. Two isolates, one
Salmonella Typhi and one Salmonella Typhimurium
(isolated in 2011 and 2013 respectively), showed de-
creased ciprofloxacin susceptibility. In the Salmonella
Typhi isolate with a MIC-value of 0.19 μg/ml for cipro-
floxacin, a gyrA resistance mutation (Asp87-Tyr/Glu133-
Gly) was detected; the Salmonella Typhimurium isolate
with a MIC of 0.25 μg/ml for ciprofloxacin also showed
a gyrA resistance mutation (Asp87-Asn). Both isolates
were resistant to nalidixic acid.
For all NTS isolates combined, MIC50 and MIC90
values for ciprofloxacin were 0.012 μg/ml and 0.047 μg/ml
respectively. The MIC50 value for ciprofloxacin of these
isolates was 0.012 μg/ml in the period 2011–2012 and
0.016 μg/ml in the period 2013–2014 while the MIC90
value increased from 0.016 to 0.047 μg/ml. All isolates
were susceptible to ceftriaxone and azithromycin.
Clinical data of children with invasive salmonellosis
according to serovar (2009–2014)
Clinical charts of children with iNTS diagnosed through
ongoing surveillance, as well as during the additional site
visits in 2012–2013, were reviewed.
A total of 91/117 (77.8 %) children with invasive
salmonellosis were < 5 years old. As expected, the me-
dian age for children with iNTS disease (24 months
(IQR 12–36)) was significantly lower as compared to
children infected with Salmonella Typhi (96 months
(IQR 48–123); p = 0.000).
For 88 out of 124 (71.0 %) children with invasive
salmonellosis clinical files were available (Tables 4 and
5). There was a significant difference in diagnosis upon
admission between iNTS disease and Salmonella Typhi
cases; the diagnosis of typhoid fever was raised in 68.8 %
of children with confirmed Salmonella Typhi infection
compared to 18.5 % of children with iNTS disease (p =
0.000). This was in line with differences in the clinical
presentation: in particular, dyspnea and pallor tended to
occur more frequently among children with iNTS disease
compared to children with Salmonella Typhi infection
(46.7 % vs. 23.1 % and 76 % vs. 38.5 % (p = 0.010) respect-
ively), while vomiting tended to be less frequent (45.3 %
vs. 69.2 %). Bivariate analysis also showed significant
differences in malaria positivity (69.3 % vs. 30.8 %; p =
0.012), anemia (98.6 % vs. 76.9 %; p = 0.010), and rate of
blood transfusions (65.3 % vs. 30.8 %; p = 0.026) between
the children with iNTS disease vs. the children with a
Salmonella Typhi infection respectively. We included these
variables in the multivariate analysis and initially stratified
for malaria positivity. In both groups (malaria positives vs.
malaria negatives), age (months) was the only variable that
remained significant with an OR similar in both groups.
We therefore decided to include malaria positivity as a
variable in the multivariable analysis. Likelihood ratio test-
ing indicated that the best model included the variables age
(adjusted OR 0.95 (95 % CI 0.93–0.97)), malaria positivity
(adjusted OR 6.31 (95 % CI 0.99–39.95) and pallor (ad-
justed OR 5.99 (95 % CI 0.95–37.77). Age remained signifi-
cant (p = 0.000) indicating that younger age is associated
with non-typhoidal Salmonella infection while malaria
positivity and pallor were borderline significant (p =
0.050 and p = 0.057 respectively).
Mortality in children with iNTS disease was 13.3 %
(10/75) compared to 7.7 % (1/13) of the children with a
Salmonella Typhi infection; this did not differ signifi-
cantly. Seventy per cent (7/10) of deaths due to iNTS
disease occurred within the first 24 h after admission.
The median age of children with a Salmonella Typhi-
murium bloodstream infection (18 months (IQR 12–30))
Table 3 Antibiotic resistance rates of 107 invasive Salmonella









n = 11 (%) n = 50 (%) n = 45 (%) n = 1
Ampicillin 5 (45.5) 44 (88.0) 43 (95.6) 1
TMP-SMX 5 (45.5) 42 (84.0) 41 (91.1) 1
Chloramphenicol 3 (27.3) 43 (86.0) 41 (91.1) 1
MDR 3 (27.3) 41 (82.0) 40 (88.9) 1
DCS 1 (9.1) 0 (0) 1 (2.2) 0
MDR + DCS 0 (0) 0 (0) 1 (2.2) 0
Nalidixic acid 1 (9.1) 0 (0) 1 (2.2) 0
TMP-SMX trimethoprim-sulfamethoxazole, MDR multi-drug resistant, DCS
decreased ciprofloxacin susceptibility
aSalmonella Group B
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was lower compared to those with a Salmonella Enteriti-
dis bloodstream infection (24 months (IQR 12–48)) but
this difference was not statistically significant (p = 0.128).
For all iNTS disease cases combined, malaria represented
the most frequent diagnosis upon admission (made in
nearly half of cases) followed by, in rank of decreasing fre-
quency, typhoid fever, pneumonia and septicemia. Malaria
was suspected more often in children with a Salmonella
Enteritidis infection compared to children with a Salmon-
ellaTyphimurium infection (65,4 % vs. 44,2 %; p = 0.032).
Table 4 Demographic, clinical and laboratory data of children with a Salmonella Typhi or non-typhoidal Salmonella infection, Oriental
Province, DRC, 2009–2014. Except for age, data represent numbers (%)
Salmonella Typhi Non-typhoidal Salmonella Bivariate analysis Multivariate analysis
Characteristics N Yes (%) N Yes (%) OR (CI) p-value aOR (CI) p-value
Demographics
Median age, months (IQR) 16 96 (48–123) 101 24 (12–36) 0.96 (0.94–0.97) 0.000 0.95 (0.93–0.97) 0.000
Male gender 16 7 (43.8) 108 63 (58.3) 1.8 (0.62–5.19) 0.277
Nutritional data (age <60 months)
Low weight-for-age 3 0 (0.0) 69 14 (20.3) * 1.000b
Very low weight-for-age 3 0 (0.0) 69 11 (15.9) * 1.000b
Symptoms at admission
Vomiting 13 9 (69.2) 75 34 (45.3) 0.36 (0.10–1.30) 0.121
Diarrhea 13 2 (15.4) 75 21 (28.0) 2.13 (0.43–10.47) 0.348
Cough 13 8 (61.5) 75 40 (53.3) 0.71 (0.21–2.38) 0.584
Dyspnea 13 3 (23.1) 75 35 (46.7) 2.91 (0.74–11.45) 0.125
Lethargy 13 9 (69.2) 75 44 (58.7) 0.63 (0.17–2.23) 0.475
Coma 13 0 (0.0) 75 1 (1.3) * 1.000b
Seizures 13 0 (0.0) 75 7 (9.3) * 0.588b
Pallor 13 5 (38.5) 75 57 (76.0) 5.06 (1.47–17.44) 0.010 5.99 (0.95–37.77) 0.057
Splenomegaly 13 3 (23.1) 69 18 (26.1) 1.17 (0.29–4.75) 0.820
Hepatomegaly 13 0 (0.0) 69 13 (18.8) * 0.115b
Antibiotic exposure <2 weeks 15 5 (33.3) 95 34 (35.8) 1.11 (0.35–3.52) 0.853
Diagnosis upon admissionc
Malaria 16 5 (31.3) 107 58 (54.2) 2.60 (0.84–8.00) 0.088
Pneumonia 16 1 (6.3) 107 17 (15.7) 2.83 (0.35–22.89) 0.329
Typhoid fever 16 11 (68.8) 107 20 (18.7) 0.10 (0.03–0.33) 0.000
Septicemia 16 0 (0.0) 107 13 (12.1) * 0.214b
Urinary tract infection 16 1 (6.3) 107 7 (6.5) 1.15 (0.12–9.14) 0.965
Gastro-intestinal tract infection 16 0 (0.0) 107 4 (3.7) * 1.000b
Meningitis 16 1 (6.3) 107 8 (7.4) 1.2 (0.13–10.28) 0.861
Other diagnosis 16 5 (31.3) 107 13 (12.0) 0.30 (0.09–1.00) 0.051
Laboratory data
Malaria diagnosisa 13 4 (30.8) 75 52 (69.3) 5.08 (1.42–18.22) 0.012 6.31 (0.99–39.95) 0.050
Anemia (Hb < 11 g/dl) 13 10 (76.9) 74 73 (98.6) 21.9 (2.07–231.40) 0.010
Severe anemia (Hb < 5 g/dl) 13 1 (7.7) 74 22 (29.7) 5.07 (0.62–41.45) 0.129
Transfusion/Outcome
Blood transfusion 13 4 (30.8) 75 49 (65.3) 4.24 (1.19–15.10) 0.026
Died in hospital 13 1 (7.7) 75 10 (13.3) 1.84 (0.21–15.78) 0.575
OR Odd’s’ratio, aOR adjusted Odd’s ratio
*Predicts failure perfectly
aMalaria diagnosis as confirmed by either thick blood film microscopy or rapid diagnostic test
bFisher exact test was used to calculate p value (other variables: logistic regression)
cDiagnoses upon admission were not included in the multivariate analysis
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The most common presenting symptom in children
with iNTS disease was pallor, observed in 76 % of all
children, followed by lethargy, cough, dyspnea, and
vomiting. Diarrhea was reported in only 28 % of the
children. The spectrum of symptoms did not differ
between the different serovars except for seizures which
were only observed in the Salmonella Typhimurium
group (7 cases only; p = 0.014).
Laboratory confirmed P. falciparum malaria was
recorded in nearly 70 % of all children with iNTS
disease; this proportion tended to be higher among
the Salmonella Enteritidis group compared to the
Table 5 Demographic, clinical and laboratory data of children with a Salmonella Typhimurium or Salmonella Enteritidis infection,
Oriental Province, DRC, 2009–2014. Except for age, data represent numbers (%)
Salmonella Typhimurium Salmonella Enteritidis Bivariate analysis
Characteristics N Yes (%) N Yes (%) OR (CI) p-value
Demographics
Median age, months (IQR) 51 18 (12–30) 47 24 (12–48) 1.00 (0.99–1.02) 0.275
Male gender 53 27 (50.9) 52 33 (63.5) 1.66 (0.77–3.56) 0.188
Nutritional data (age <60 months)
Low weight-for-age 38 8 (21.1) 30 6 (20.0) 0.93 (0.28–3.07) 0.915
Very low weight-for-age 38 6 (15.8) 30 5 (16.7) 1.06 (0.29–3.90) 0.922
Symptoms at admission
Vomiting 40 17 (42.5) 33 16 (48.5) 1.27 (0.50–3.21) 0.609
Diarrhea 40 9 (22.5) 33 12 (36.4) 1.96 (0.70–5.49) 0.196
Cough 40 25 (62.5) 33 15 (45.5) 0.5 (0.19–1.27) 0.147
Dyspnea 40 19 (47.5) 33 16 (48.5) 1.04 (0.41–2.61) 0.933
Lethargy 40 22 (55.0) 33 21 (63.6) 1.43 (0.55–3.67) 0.456
Coma 40 1 (2.5) 33 0 (0.0) * 1.000b
Seizures 40 7 (17.5) 33 0 (0.0) * 0.014b
Pallor 40 29 (72.5) 33 28 (84.8) 2.12 (0.65–6.89) 0.210
Splenomegaly 37 7 (18.9) 30 11 (36.7) 2.48 (0.81–7.51) 0.108
Hepatomegaly 37 6 (16.2) 30 7 (23.3) 1.57 (0.46–5.30) 0.466
Antibiotic exposure < 2 week 49 15 (30.6) 44 19 (43.2) 1.72 (0.73–4.03) 0.211
Diagnosis upon admission
Malaria 52 23 (44.2) 52 34 (65.4) 2.38 (1.07–5.25) 0.032
Pneumonia 52 9 (17.3) 52 7 (13.5) 0.74 (0.25–2.17) 0.588
Typhoid fever 52 11 (21.2) 52 8 (15.4) 0.67 (0.24–1.85) 0.448
Septicemia 52 5 (9.6) 52 8 (15.4) 1.70 (0.51–5.62) 0.378
Urinary tract infection 52 1 (1.9) 52 4 (7.7) 4.25 (0.45–39.38) 0.203
Gastro-intestinal tract infection 52 3 (5.7) 52 1 (1.9) 0.32 (0.03–3.18) 0.331
Meningitis 52 4 (7.7) 52 4 (7.7) 1.00 (0.23–4.23) 1.000
Other diagnosis 52 6 (11.5) 52 7 (13.5) 1.19 (0.37–3.82) 0.767
Laboratory data
Malaria diagnosisa 40 25 (62.5) 33 27 (81.8) 2.7 (0.90–8.04) 0.075
Anemia (Hb < 11 g/dl) 39 38 (97.4) 33 33 (100) * 1.000b
Severe anemia (Hb < 5 g/dl) 39 10 (25.6) 33 12 (36.4) 1.65 (0.60–4.54) 0.327
Transfusion/Outcome
Blood transfusion 40 25 (62.5) 33 24 (70.6) 1.60 (0.58–4.34) 0.356
Died in hospital 40 7 (17.5) 33 3 (9.1) 0.47 (0.11–1.98) 0.306
OR Odd’s’ratio
*Predicts failure perfectly
aMalaria diagnosis as confirmed by either thick blood film microscopy or rapid diagnostic test
bFisher exact test was used to calculate p value (other variables: logistic regression)
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Salmonella Typhimurium group (62.5 % vs. 81.8 %;
p = 0.075).
There was no significant difference in mortality be-
tween children infected with Salmonella Enteritidis
and Salmonella Typhimurium.
Overall, 35,5 % (39/110) of patients with a Salmonella
bloodstream infection reported previous antibiotic
exposure.
Discussion
The present study describes the clinical, microbiological
and molecular characteristics of invasive Salmonella in-
fections in the Oriental Province during the surveillance
period 2009–2014, including data from outreach visits to
more remote areas in the province during an epidemic
increase of malaria in 2012.
During the surveillance period, the proportion of Sal-
monella among pathogens from blood cultures varied
between 25.0 and 42.3 %, which is consistent with other
studies from sub-Saharan Africa [2, 35–37]. There was a
predominance of serovars Salmonella Typhimurium and
Salmonella Enteritidis that were isolated in equal num-
bers but with proportions varying over time which is
also in line with other studies from sub-Saharan Africa
[1, 38, 39]. There was a particular high percentage
(88.9 %) of Salmonella among the pathogens isolated
from blood cultures in the health zones affected by the
epidemic increase in malaria in June 2012. During subse-
quent outreach visits between October 2012-January
2013 (period after the epidemic increase in malaria), this
proportion subsequently decreased to only 26.3 %. The
latter percentage is more in line with the averages at the
provincial level, and suggests that the epidemic increase
of malaria was associated with a concomitant increase in
Salmonella bloodstream infections. Possibly, the data
represented here are an underestimation of the actual
number of patients co-infected with malaria and NTS.
Other studies have shown that case fatalities are higher for
children who are co-infected with NTS compared to those
infected with malaria alone and, in the present study, part
of them might have died before reaching the hospital [40].
The clinical presentation of iNTS disease in this study
was dominated by pallor, lethargy, gastro-intestinal and
respiratory symptoms. A concomitant infection with
pneumococci has been forwarded to explain the preva-
lence of respiratory symptoms during iNTS disease but
the dyspnea could also be related to the high prevalence
of anemia among children with iNTS disease or to the
acidosis due to sepsis in general [2]. There were no
statistically significant differences between the character-
istics of Salmonella Typhimurium and Salmonella
Enteritidis bloodstream infections except for occurrence
of seizures but this was probably affected by a small
sample size.
Children with a Salmonella Enteritidis bloodstream in-
fection tended to suffer from concomitant malaria more
frequently compared to those infected with Salmonella
Typhimurium. We are not aware of other studies that
pointed to a particular association of Salmonella Enteri-
tidis with concurrent malaria infection. More extensive
and prospective research is needed to evaluate this find-
ing further.
Overall, more than two-thirds of the children with
iNTS disease tested positive for P. falciparum malaria
which was also previously reported from Bwamanda in
the DRC [16]. It is known that P. falciparum malaria
predisposes to iNTS disease [7–9, 41, 42] and several re-
cent studies have revealed probable underlying mecha-
nisms [7, 43–45]. In the case of the Oriental Province,
no clear reason for the upsurge in malaria was identified.
The fact that during the end of the dry season less than
average rainfall was observed might have played a role in
the increase of malaria infections. Also, the influx of per-
sons from conflict areas in the Kivu provinces, that have
lower exposure to malaria compared to the Oriental
Province (annually averaged infection prevalence of mal-
aria in 2–10 year olds (<5 %) compared to >40 % re-
spectively), might have contributed to the increase [46].
Besides malaria, other known risk factors for contract-
ing iNTS disease are HIV, sickle cell anemia and malnu-
trition. It is estimated that 12 % of the hospitalized
children in the DRC have sickle cell anemia [47]. For
HIV, rates among pregnant women in the different dis-
tricts of the Oriental Province varied between 4.5 and
6.2 % (Table 1). In the study cohort described, severe
malnutrition was not very common.
As there was also clinical data available for 13 children
with a Salmonella Typhi infection, differences with iNTS
cases could be explored. Vomiting was more prevalent
among children infected with Salmonella Typhi com-
pared to those with iNTS disease. Mtove et al. (2010)
had similar observations in a study from rural Tanzania
(71.3 % of Salmonella Typhi cases vs. 53.4 % of iNTS
disease cases) [11]. In bivariate analysis, significantly less
children infected with Salmonella Typhi had pallor,
anemia, need for blood transfusion and were less fre-
quently tested positive for malaria compared to the
children with iNTS. In the study of Mtove et al. (2010)
children with Salmonella Typhi infections did not show
pallor or severe anemia but children with iNTS did in
respectively 62.2 and 40.0 % of the cases [11]. Other
studies have also described high numbers of patients
with iNTS disease receiving blood transfusions [39, 42].
The final regression model included the variables age,
malaria positivity and pallor, but only younger age
remained significantly associated with non-typhoidal
Salmonella infection. These results should be interpreted
with caution however given the small sample sizes.
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Unlike the epidemic increase of iNTS in Kisantu –
which was only identified upon retrospect –the
Oriental Province health authorities were alerted to
the possibility of an increase in iNTS disease in con-
currence with the observed increase in malaria cases.
As a consequence, empirical antibiotic treatment was
installed early on in the epidemic and this may have
accounted for the relatively low case-fatality among
the microbiologically confirmed iNTS cases in our co-
hort. This rate is similar to that found during the
outbreak in Bwamanda [16] but lower to that found
in Kisantu (23.0 %) [15], the latter being more in line
with case fatality rates more frequently reported for
iNTS [2, 4]. In addition, given the large surface and
geographical inaccessibility of the affected districts in
the Oriental Province, with a swamp environment
and absence of paved roads, many children are ex-
pected to have died at home or during their way to
the health care center or hospital. The fact that most
documented in-hospital deaths occurred within 24 h
after admission supports this hypothesis.
Antibiotic susceptibility testing showed high MDR
rates among NTS isolates; only two Salmonella isolates
showed decreased ciprofloxacin susceptibility. However,
MIC50 and MIC90 values for ciprofloxacin were higher
in the period 2013–2014 compared to the period 2011–
2012 which is a worrisome trend.
MLVA profiles of Salmonella Enteritidis isolates
showed that two closely related profiles accounted for
73.2 % of all the tested isolates. The two major profiles
only differed with one tandem repeat at one single locus
suggesting very close relatedness [28]. MLVA profiles of
the Salmonella Enteritidis isolates implicated in the
epidemic increases in Kisantu and Bwamanda also
showed very close relatedness [28]. Whole genome
sequencing of these isolates could provide more insight
in the clonality of Salmonella Enteritidis associated with
iNTS disease.
Salmonella Typhimurium isolates were more hetero-
geneous than Salmonella Enteritidis isolates with the
two most common MLVA profiles accounting for only
24.1 % of all tested isolates. The major profile isolated
from the Haut-Uélé district differed by 1–2 tandem
repeats at two loci compared to the major profiles
isolated in the Tshopo district. Previous reports on
epidemic increases of NTS infections in the DRC did
not consider the MLVA profiles for Salmonella Typhi-
murium. A previous study did assess the population
structure of 180 Salmonella Typhimurium isolates
collected in the DRC between 2007 and 2011 with
CRISPOL typing and found that >96 % belonged to
the CT28 group [48]. This group has a strong associ-
ation with Salmonella Typhimurium multilocus se-
quence type (ST) 313 which is associated with
bloodstream infections and high rates of antimicrobial
drug resistance. Also in other Sub-Saharan countries,
the majority of isolates are found to be ST 313 [49].
Future research will include genomic sequencing of
Salmonella Typhimurium isolates from different parts
of the DRC, including isolates from the Oriental
Province, Kisantu and Bwamanda.
The present study had several limitations, mostly
owing to its retrospective nature. First, the outreach
visits to the HZs were – due to logistic and administra-
tive constraints – organized at a period considerably
after the first alerts of increased admissions and malaria
cases. Next, there was no clearly defined population size
denominator, precluding calculation of population-based
incidence rates. In addition, it could not be ascertained
how many children died at home or on their way to the
hospital, precluding accurate estimates of case-fatality
rates. Furthermore, not all isolates, patients’ files and
hospital registers were available for analysis. Other diffi-
culties included accessibility of the affected districts re-
quiring for instance transport of samples by motorbikes
on deteriorated roads and subsequent shipment by a
small airplane carrier (at a distance of 350 km) to
CUKIS, the single diagnostic microbiology laboratory in
the Oriental Province.
There were also limitations with regard to laboratory
data: no distinction could be made between recent
(microscopy negative but rapid diagnostic test positive)
versus current malaria (microscopy positive), and the
quality of malaria diagnosis probably differed per med-
ical center. The limitations of measuring hemoglobin
levels with the Sahli method should be kept in mind es-
pecially as no quality control for harmonization was
performed.
Finally, it was not possible to compare the clinical
characteristics of children with iNTS disease to the other
children admitted, precluding a control group. Also,
sampling of the affected health districts was mainly re-
stricted to the year 2012, not allowing for comparisons
with years before and after.
Sampling during the surveillance period was however
constant over time and directed by a set of clinical indi-
cations, and clear comparisons with other years could be
made. We believe this was also the case for the hospital
registers providing compiled data about malaria diagno-
sis and blood transfusions.
Despite the limitations, this study offers valuable
data on a neglected disease from an under investi-
gated area collected during a time of great political
instability. Previous articles have highlighted the need
for studies that combine epidemiological, micro-
biological and clinical data on iNTS disease [5]. Last,
the study allowed for a comparison between the most
dominant NTS serovars.
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Future studies should estimate reliable population in-
cidence rates. The development of an (antigen based)
rapid diagnostic test would be highly welcome as a tool
for diagnosis in low resource settings where micro-
biological facilities are often absent. More research is also
needed on differences between the clinical presentation
and outcome of both Salmonella Typhimurium and Sal-
monella Enteritidis serovars. Whole genome sequencing
of NTS isolates from different areas in the DRC, especially
those related to local increases in infections, would pro-
vide valuable insights. It is obvious that continued blood
culture surveillance is imperative to monitor the propor-
tions and distributions of NTS serovars as well as their
antibiotic resistance patterns. Last, efforts to control the
increase in malaria in this region should be intensified.
Conclusion
The present observations confirm NTS as a leading
cause of bloodstream infection in an area holoendemic
for P. falciparum malaria. A sudden increase in hospital
admissions among children < 5 years old, associated with
a laboratory-confirmed diagnosis of P. falciparum mal-
aria needs to raise the suspicion of a concomitant
increase in NTS infections, particularly if associated with
an increase in blood transfusions and case-fatality.
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